XRAY News and Press, DENTSPLY SIRONA Inc. From 05/02/23

2023-05-02 12:46:09 ET Dentsply Sirona ( NASDAQ: XRAY ) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, before market open. The consensus EPS Estimate is $0.34 (-34.6% Y/Y) and the consensus Revenue Estimate is $938.16M (-2.8% Y/Y). Over the last 2 ...

Dentsply Sirona, FDI World Dental Federation and Smile Train deliver the first-ever global protocols for digital cleft treatment PR Newswire As part of its sustainability strategy "BEYOND: Taking action for a brighter world", Dentsply Sirona entered a three-way partnership wit...

2023-04-09 03:20:02 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

CHARLOTTE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, May 3, 2023, at 8:30 am ET ...

2023-03-25 10:44:38 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For furthe...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY). On April 19, 2022, the Company disclosed the sudden t...

2023-03-08 04:29:49 ET Summary Dentsply's financial performance is weaker compared to last year. The management is transparent and has provided a clear path toward a positive turnaround. It has an improving product portfolio, which will aid growth in its US operation. It r...

2023-03-06 08:39:19 ET Dentsply Sirona ( NASDAQ: XRAY ) plans to repurchase $150M of its common stock through an accelerated share repurchase agreement with Goldman Sachs. The agreement will be completed under Dentsply Sirona’s current share repurchase authorization...

Summary Atrion Corporation has done well from a sales perspective very recently, but its overall financial performance in recent years has been disappointing. This is especially true of bottom line results that have shown no real growth. The firm is a stable operator that should be ...

DENTSPLY SIRONA Inc. (XRAY) Q4 2022 Earnings Conference Call February 28, 2023 08:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Conference Call Partic...